VEGFA and proliferative diabetic retinopathy: Two relatively recent prospective randomized clinical trials examined the treatment efficacy of intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) in patients with proliferative diabetic retinopathy (PDR) [1, 2].